Shares ofAnika Therapeutics Inc(NASDAQ:ANIK), a small-cap biotech focused on regenerativemedicine, were down 36% as of 11:10 a.m. EDT on Tuesday. The stock plummetedafter the company reported data from an important phase 3 study.
Headlines about Spherix (NASDAQ:SPEX) have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale
WASHINGTON New Jersey won a landmark ruling from the Supreme Court Monday that could lead many states to legalize betting on college and professional sports.
The justices ruled 7-2 that a 25-year-old federal law that has effectively prohibitedsports betting outside Nevada by forcing states to keep prohibitions on the books is unconstitutional. The ruling could set the stage forother states....More>>>
General Motors (GM) just jumped after a short upbeat earnings call, and deservedly so, as it has lagged the market considerably since 2011. I’m going to take this opportunity to give CEO Barra some credit. A lot of exciting stuff is happening at General Motors, like 1) its operations are throwing off cash; 2) they are cutting loose underperforming parts; 3) there’s future optionality....More>>>
Field & Main Bank grew its stake in shares of Amgen (NASDAQ:AMGN) by 9.1% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,153 shares of the medical research company’s stock after buying an additional 345 shares during the quarter. Field & Main Bank’s holdings in Amgen were worth $708,000 at the....More>>>
Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.
Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage....More>>>
Right now, there’s a major shift underway in the biotech field that’s creating a brand-new $59.2 billion industry. And investors who get in now could be positioning themselves for triple- or even quadruple-digit gains…
That’s why we’re bringing readers one of the best biotech stocks to buy in December 2017, according to Money Morning Director of Technology....More>>>
Federal Reserve Board Chairwoman Janet Yellen testifies before the Senate Banking, Housing and Urban Affairs Committee February 14, 2017 in Washington, DC. Yellen testified on the topic of on ‘The Semiannual Monetary Policy Report to Congress.’ (Photo by Win McNamee/Getty Images)
All signals suggest that The Federal Reserve will increase rates this week, traders suggest there’s....More>>>
Wealthstreet Investment Advisors LLC cut its stake in Cisco Systems, Inc. (NASDAQ:CSCO) by 1.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 131,935 shares of the network equipment provider’s stock
So far this year Boeing (BA) is having a strong start looking at its financial results, but also when looking at the order book the jet maker is seeing some appreciable order inflow. One of the programs that could use some order inflow to avoid a further cut in production is the Boeing 777 progr
Being a member of the esteemed Dow Jones industrial average index is supposed to come with prestige. After all, there are only 30 companies at a time that can actually be a Dow stock. These companies are supposed to represent a major portion of the industrial business climate or to dominate a ma
Gatorade Zero, a thirst quencher without sugar or carbs, hit stores around the country this week. It comes in orange, lemon lime, and glacier cherry, and is priced in line with the brand's classic sports drink.
United Technologies Co. (NYSE:UTX) has been given a consensus recommendation of “Buy” by the twenty research firms that are covering the stock, Marketbeat.com reports. Seven analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Th